KORU Medical Systems
Enhancing Patients’ Independence through Subcutaneous Drug Delivery

Managing chronic conditions like Primary Immunodeficiency Disease (PIDD) requires a coordinated approach, often putting patients’ lives on hold. What if there was a drug delivery system so intuitive that it gives patients the freedom to truly live and receive medicine in harmony with their body’s natural processes?

The answer lies with KORU Medical Systems.

According to Brent Rutland, KORU’s Vice President of Global Medical Affairs, “Pharmaceutical companies and specialty pharmacies excel at understanding how drugs behave once administered, but they often need assistance with the delivery process. We help clients navigate the complexities of drug delivery by ensuring accurate requirements for flow rate, volume, and timing.”

As a global manufacturer specializing in large-volume (over 5 mL) subcutaneous drug infusion devices, KORU has developed innovative, easy-to-use medical devices aptly named Freedom. These devices are designed to support patients and healthcare providers managing chronic illnesses such as Primary Immune Deficiency Diseases (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

The system consists of three main components: the pump (Freedom60^® or FreedomEDGE^®), the tubing (Precision™ Flow Rate Tubing), and the needle set (High-Flo™ Subcutaneous Safety Needle Sets).

The pump uses a mechanical spring-based system to ensure consistent medication delivery without batteries or electricity, making it suitable for at home or outdoors. The Precision™ Flow Rate Tubing acts as a rate limiter, delivering medication at the prescribed flow rate. The High-Flo™ Subcutaneous Safety Needles are designed for easy insertion, minimizing discomfort. Together, these components allow patients to manage drug and fluid administration, giving them the freedom to be wherever they choose, and away from clinical settings.

We help clients navigate the complexities of drug delivery by ensuring accurate requirements for flow rate, volume, and timing.

For drug manufacturers transitioning from vials to prefilled syringes, KORU assists with the necessary adjustments for different drug formats, providing the expertise and equipment needed for safe and effective delivery.

KORU collaborates with specialty pharmacies to meet patient needs effectively, including facilitating drug switches when necessary. By offering tailored support and resources, KORU helps manage the complexities of medication delivery to enhance patient care and outcomes.

Continuous improvement and innovation are integral to KORU’s mission. At the patient level, the company conducts time and motion studies to identify challenges and develop solutions that enhance the user experience, making devices more intuitive and adaptable. KORU’s innovations have positioned it as the preferred choice for large-volume subcutaneous drug delivery among patients, healthcare providers, specialty pharmacies, and pharmaceutical partners.

KORU’s team of experts – from diverse industry backgrounds – provides the company with a real competitive advantage in subcutaneous drug delivery. The R&D team drives innovation. The medical affairs team educates pharmaceutical companies, pharmacists, and patients worldwide. The regulatory department skillfully navigates approval processes in both Europe and the U.S. The commercial team develops effective solutions for clients. Finally, the manufacturing team ensures that products are safe, reliable, and ready for global distribution.

KORU’s mission is to empower patients with the freedom to live fully. As recent advancements in chronic disease treatments show, subcutaneous drug delivery is becoming the preferred method due to its ease of use. KORU is at the forefront of this movement, committed to shaping the future of subcutaneous drug delivery and making quality healthcare accessible to all.